Astrantus’s Teladoc Health TDOC Stock Holding History

Astrantus’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$368K	Buy	5,100 +1,400	+38%	+$101K	0.62%	72
2021 Q4	$340K	Buy	+3,700	New	+$442K	0.25%	152

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Astrantus's TDOC Position: Q1 2022 in Review

Astrantus increased its Teladoc Health (TDOC) stake by 38% in Q1 2022, buying an estimated $101K and bringing the position to 5,100 shares worth $368K. The position accounts for 0.62% of the portfolio, ranked #72.

Astrantus first reported a position in TDOC in Q4 2021 and has held it in 2 quarters since. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

Astrantus held 5,100 shares of Teladoc Health worth $368K as of Q1 2022.
Astrantus bought 1,400 Teladoc Health shares in Q1 2022, an estimated $101K.
Teladoc Health made up 0.62% of Astrantus's portfolio in Q1 2022, its #72 holding.
Astrantus first reported a position in Teladoc Health in Q4 2021 and has held it in 2 quarters since.
680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.